Neurology
Findings from Greece and the United States describe new data in neurology research
Published in Gene Therapy Weekly, August 10th, 2006
Study 1: According to recently published research from Greece, genetically engineered Schwann cells show enhanced migratory potential without impairment of their myelinating ability in vitro.
"Schwann cells, the myelin-forming cells of the PNS, are attractive candidates for remyelination therapy as they can remyelinate CNS axons. Yet their integration in CNS tissue appears hampered, at least in part, by their limited motility in the CNS environment," wrote A.A. Lavdas and colleagues, Hellenic Pasteur Institute.
They continued, "As the polysialylated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-08-10)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Ribonucleic acid interference targeting suppresses anaplastic thyroid carcinoma - DNA Research
Integrated expression vectors enable site-directed knockout - Developmental Biology
Retinal cell development affected by gene interference - RNA Research
RNA transfection allows investigation of endothelin posttranscriptional regulation - RNA Research
Short hairpin RNA-expressing bacteria elicit RNA interference in mammals - Allergy & Immunology
Allergic inflammation is modified by different bacterial ligands in a rhinitis model - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
